在素降解肠道共生体 Akkermansia muciniphila 的药物活性化β-glucuronidase上的结构功能研究
Tarushi1,2, Gagan Deep Gupta1,2, Mukesh Kumar1,2
1Protein Crystallography Section, Bhabha Atomic Research Centre, Mumbai, India.
Journal of biomolecular structure & dynamics
|May 4, 2025
概括
我们发现AmGUS是一种来自Akkermansia muciniphila的新型β-glucuronidase,它可以切割抗癌药物SN38. 这种酶可能会导致药物毒性,并且代表了一种新的GUS酶类.
科学领域:
- 微生物学 微生物学
- 酶学 是一种酶学.
- 结构生物学 结构生物学
背景情况:
- 肠道微生物β-glucuronidases (mGUS) 影响激素调节,神经递质活性和异生物代谢.
- mGUS的活性可以通过促进诸如伊利诺坦 (SN-38) 等抗癌药物的肠肝循环,导致严重的腹.
研究的目的:
- 为了表达,净化和表征AmGUS,一种来自肠道共生体Akkermansia muciniphila的新型β-glucuronidase.
- 为了研究AmGUS的基质特异性和结构性质.
- 探索AmGUS在抗癌药物代谢中的潜在作用.
主要方法:
- 阿姆古斯的表达和净化.
- 酶活性测试以确定基质特异性.
- 用于AmGUS.US结构分析和分类的计算建模.
主要成果:
- AmGUS对葡萄糖化物基质表现出特异性,并有效地分裂SN38.38的葡萄糖化形式.
- 与其他已知的GUS酶不同,AmGUS作为单体起作用.
- 结构分析表明AmGUS属于一种新的GUS酶类,具有独特的活性位点循环,包括一个新的N终端循环.
结论:
- 来自A. muciniphila的AmGUS代表了一类具有独特结构特征的β-glucuronidases的新类.
- 该酶对SN38的活性表明它在药物的肝内循环和潜在的毒性中起作用.
- 了解AmGUS提供了对人类肠道微生物群的GUSome和A. muciniphila的殖民性的见解.
相关概念视频
Phase II Reactions: Glucuronidation
147
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
147
Drug Metabolism: Phase II Reactions
3.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.4K


